Cardiovascular Journal of Africa: Vol 30 No 3 (May/June 2019)

45 / 68

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 3, May/June 2019 AFRICA 173
Dickstein K, et al. ESC guidelines for the diagnosis and treatment
of acute and chronic heart failure 2012. Eur J Heart Fail 2012; 14(8):
803–869.
14. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical
risk stratification for predicting stroke and thromboembolism in atrial
fibrillation using a novel risk factor-based approach: the euro heart
survey on atrial fibrillation. Chest 2010; 137(2): 263–272. .
org/10.1378/chest.09-1584.
15. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A
novel user-friendly score (HAS-BLED) to assess 1-year risk of major
bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest
2010; 138(5): 1093–1100.
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka
PA, et al. Recommendations for chamber quantification: a report from
the American Society of Echocardiography’s Guidelines and Standards
Committee and the Chamber Quantification Writing Group, developed
in conjunction with the European Association of Echocardiography, a
branch of the European Society of Cardiology. J Am Soc Echocardiogr
2005; 18(12): 1440–1463.
7317(05)00983-1/fulltext.
17. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr, Drazner MH,
et al. 2013 ACCF/AHA guideline for the management of heart failure:
a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol
2013; 62(16): e147–239.
18. Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al.
2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary
hypertension: The Joint Task Force for the Diagnosis and Treatment
of Pulmonary Hypertension of the European Society of Cardiology
(ESC) and the European Respiratory Society (ERS): Endorsed by
Association for European Paediatric and Congenital Cardiology
(AEPC), International Society for Heart and Lung Transplantation
(ISHLT). Eur Heart J 2016; 37(1): 67–119.
eurheartj/ehv317.
19. Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira
B, et al. Rheumatic heart disease screening by echocardiography: the
inadequacy of World Health Organization criteria for optimizing the
diagnosis of subclinical disease. Circulation 2009; 120(8): 663–668.
20. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ,
et al. 2016 ESC guidelines for the diagnosis and treatment of acute and
chronic heart failure: The Task Force for the diagnosis and treatment of
acute and chronic heart failure of the European Society of Cardiology
(ESC). Developed with the special contribution of the Heart Failure
Association (HFA) of the ESC. Eur J Heart Fail 2016; 18(8): 891–975.
21. Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W,
et al. Updated European Heart Rhythm Association practical guide on
the use of non-vitamin-K antagonist anticoagulants in patients with
non-valvular atrial fibrillation: Executive summary. Eur Heart J 2017;
38(27): 2137–2149.
22. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC,
Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients
with atrial fibrillation: executive summary: a report of the American
College of Cardiology/American Heart Association Task Force on prac-
tice guidelines and the Heart Rhythm Society. Circulation 2014; 130(23):
2071–2104.
23. Thomas KL, Jackson LR, 2nd, Shrader P, Ansell J, Fonarow GC, Gersh
B, et al . Prevalence, characteristics, and outcomes of valvular heart
disease in patients with atrial fibrillation: insights from the ORBIT-
AF (Outcomes Registry for Better Informed Treatment for Atrial
Fibrillation). J Am Heart Assoc 2017; 6(12).
jaha.117.006475.
24. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban
P, et al. Atrial fibrillation in Africa: clinical characteristics, progno-
sis, and adherence to guidelines in Cameroon. Europace 2010; 12(4):
482–487.
25. Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, et al.
Predisposing factors and incidence of newly diagnosed atrial fibril-
lation in an urban African community: insights from the Heart of
Soweto Study. Heart 2010; 96(23): 1878–1882.
hrt.2010.206938.
26. Temu TM, Lane KA, Shen C, Ng’ang’a L, Akwanalo CO, Chen PS,
et al. Clinical characteristics and 12-month outcomes of patients with
valvular and non-valvular atrial fibrillation in Kenya. PLoS One 2017;
12(9): e0185204.
27. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart
S. Incidence and characteristics of newly diagnosed rheumatic heart
disease in urban African adults: insights from the heart of Soweto study.
Eur Heart J 2010; 31(6): 719–727.
ehp530.
28. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola
VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospital-
ized acute heart failure patients: description of population. Eur Heart
J 2006; 27(22): 2725–2736.
29. Mwita JC, Dewhurst MJ, Magafu MG, Goepamang M, Omech B,
Majuta KL, et al . Presentation and mortality of patients hospitalised
with acute heart failure in Botswana. Cardiovasc J Afr 2017; 28(2):
112–117.
30. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds
K, et al. Global disparities of hypertension prevalence and control:
a systematic analysis of population-based studies from 90 countries.
Circulation 2016; 134(6): 441–450.
naha.115.018912.
31. Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido
B, et al. Characteristics, complications, and gaps in evidence-based
interventions in rheumatic heart disease: the Global Rheumatic Heart
Disease Registry (the REMEDY study). Eur Heart J 2015; 36(18):
1115–1122.
32. Mwita JC, Magafu M, Omech B, Tsima B, Dewhurst MJ, Goepamang
M, et al. Undiagnosed and diagnosed diabetes mellitus among hospital-
ised acute heart failure patients in Botswana. SAGE Open Med 2017; 5:
2050312117731473.
33. Holmes MD, Dalal S, Volmink J, Adebamowo CA, Njelekela M, Fawzi
WW, et al. Non-communicable diseases in sub-Saharan Africa: the
case for cohort studies. PLoS Med 2010; 7(5): e1000244. .
org/10.1371/journal.pmed.1000244.
34. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al.
Temporal relations of atrial fibrillation and congestive heart failure
and their joint influence on mortality: the Framingham Heart Study.
Circulation 2003; 107(23): 2920–2925.
cir.0000072767.89944.6e.
35. Mwita JC, Francis JM, Oyekunle AA, Gaenamong M, Goepamang M,
Magafu M. Quality of anticoagulation with warfarin at a tertiary hospi-
tal in Botswana. Clin Appl Thromb Hemostasis 2018; 24(4): 596–601.